) .
(SCG). [2, 3] patients registered at the epilepsy clinic. Direct treatment- clinic of a state university hospital located in the capital city of Andhra Pradesh, a province in south India. We included only patients with new-onset seizures who had not received any specific treatment or AEDs. All patients were treated with AED monotherapy (phenytoin or carbamazepine) for the period of CT resolution of the lesion. Drug dose was based on the body weight and clinical response and no drug monitoring was done. They also received a course of albendazole (15 mg/kg per day for four weeks) and steroids (1-2 mg/kg per day for four weeks with tapering dose). All patients were treated in the outpatient clinic. AED withdrawal was gradual over a period of two months. Patients were advised not to come for further follow-up after stopping AEDs. 
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Estimation of direct costs For direct costs' analysis of those costs required to manage the illness, direct treatment-related costs, after registration in the epilepsy clinic were considered. These included costs of medications, doctor contacts at all levels, investigations (EEG and CT scan) and nonmedical costs (transportation). For investigations the tariffs of the hospital (Indian National Rupee, INR) at the time of data collection were considered [ Table 1 ]. While calculating the transportation costs the actuals spent by the patient percentage of gross national product (GNP) at current prices for the year 1997-98, INR 137694.3 billion (US$ 31918 billion) and per capita GNP at current prices INR 14, 284 (US$ 296.72) .
[10] To make international cost comparisons, costs in US dollar (US$) and International Dollars (I$) were also calculated. The calculation is obtained by adjusting for the purchasing power parity (PPP) factor 5.4. [11] Results and accompanying persons from their place of living, including transportation from bus or railway station to
The demographic data was: mean age: 18.11 years (range our institute were considered. The cost of AEDs was 11-26); male to female distribution: 35:24; the mean calculated using the prices for the brand-name products number of seizures before registration: 3.95 (range 1-6) in INR. These prices included basic net and local taxes. and the total duration of illness 11.71 months (range 1
All patients had one interictal EEG and brain CT at the 14). Twelve patients (20%) had three CT scans and three time of registration. First repeat CT scan was done after (5%) had four CT scans before AED withdrawal. The six months of the index scan. This time interval for the treatment protocol was safe and effective [ Table 2 ]. No first scan was based on the data that a greater proportion patient required hospitalization with this treatment of lesions would resolve partially or completely by six protocol. months and repeat CT examinations could be avoided in
The direct cost per patient treated with AEDs for the a substantial proportion (67%) of patients.
[8] In patients period of resolution of CT lesion and a course of in whom CT scan showed persistence of the lesion, CT albendazole and steroids was INR 5916 (US$ 137.14; was repeated at three-month intervals till the lesion 41.4% of per capita GNP). If the patient had received only disappeared. Patients in whom the lesion got calcified AEDs for the period of resolution of CT lesion, the cost were excluded from the analysis because some of these would be INR 5702.48 (US$132.2; 40% of per capita GNP). patients may develop remote symptomatic epilepsy. [6, 7, 9] A patient would be spending 3.6% (INR 213.7, US$ 4.95, 1.5% of per capita GNP) of the total direct cost on Estimation of indirect costs albendazole and steroids and it accounted for 20.7% of Productivity loss was measured by the number of lost total medication costs [ Table 3 ]. man-days due to recurrence of seizures and also due to
The number of days lost due to seizures for the total travel for follow-up visit. In the case of students, cohort after starting treatment was 32 days. Days lost due productivity loss was measured by the number of days to travel for follow-up visits for the entire cohort were they abstained from school or college. While calculating 170 days. This included 65 student days lost. It was 162 wage losses for the daily wage earners, the actual wages days for the parents and/or relatives. Total wage loss was were calculated. For people who were employed the actual losses were calculated. For students only man-days lost 
Mean frequency of seizures
In patients with < 6 months duration 0.66 (0-2) 0.87
Cost calculation
The cost per person was computed as the mean cost for the whole cohort. The relative cost was calculated as the INR 77450 (US$ 1801.2). Indirect cost (wage loss) per patient was INR 1312.7 (US$ 30.42, 9% of per capita GNP) [ Table 4 ]. The total COI for treating seizure disorder associated with SCG for the period of resolution of CT lesion per patient was INR 7273.7 (US$ 174.66; I$ 943.16) and he/ she would be spending 50.9% of per capita GNP.
In our community-based Comprehensive Rural Epilepsy Study South India (CRESSI), the prevalence of seizure disorder associated with SCG was 0.10 per 1000 for two reasons: (i) seizures are likely to recur as long as the lesion persists and (ii) the time period for the resolution of the CT lesion is quite variable. There is abundant evidence to suggest that AEDs can safely be withdrawn once the follow-up scan shows resolution of the lesion. [14] The place of cysticidal therapy in patients with SCG is not clear. The argument against cysticidal therapy is that seizures associated with this lesion are because of the inflammatory response of the brain and the lesions are known to resolve spontaneously.
[1] However, the results population (unpublished data), this was the only such of the meta-analysis of the cysticidal drug trials in the study in the country. Extrapolating these figures to the treatment of NCC suggests that in patients with enhancing present population of India (1.107 billion -2005-2006) [10] lesions, the risk for seizure recurrence is lower after the number prevalence cases of seizure disorder associated cysticidal treatment and also trend toward lesion with SCG in India would be 110,700. After adjusting for resolution. [15] Based on these findings our approach to the inflation, the projected one-time expenditure to the treat these patients with a course of cysticidal therapy nation to treat all the prevalence cases is to the tune of and AEDs for the period of resolution of CT lesion has a INR 1.184 billion (US$ 2.605 million), which is 0.003% good rationale. In this study the additional cost for this of total GNP (GNP at current prices 2005 . added therapy accounted for 3.6% of the total COI. 49 billion).
[10]
Neurocysticercosis is of great economic relevance, resulting from the cost of medical treatment, lost working Discussion days and losses due to livestock condemnation. [16] developing countries seizure disorder associated with The current environment of cost consciousness in NCC represents a significant proportion of the treatable healthcare has resulted in a need for the economic burden of disease. But the developing world with evaluation of different treatments in order to identify those population five times the size of the developed world which provide the most value for money in treating has at its disposal only 25% of the global total gross patients. This has much more relevance for developing domestic product (GDP) and 5% of the global per capita countries. In developing countries the per capita GDP. [16] [17] [18] [19] A minimum estimate of the cost of admission to expenditure on healthcare is very minuscule and in India hospital and wage loss for NCC in the United States (a the expenditure is only US $21 and 78% of the cost of nonendemic country) was US$ 8.8 million annually, healthcare is paid by patients. [12] The results of the present whereas estimated treatment costs in Mexico were US$ economic evaluation indicate that under base-case 89 million and in Brazil US$ 85 million. [20] assumptions patients with seizures associated with SCG study one-time expenditure (after adjusting for the need AED therapy for the period of resolution of CT lesion, inflation) to the nation to treat all the prevalence cases of this approach is safe and effective. However, the patient seizure disorder associated with SCG in India is US$ will be spending a considerable proportion of his/her per 2.605 million (0.0038% of total GNP at current prices). capita GNP, that is 50.9%.
There are no incidence studies to project the likely annual The treatment of seizures associated with SCG is highly costs to treat the seizure disorder associated with this In From this variable. Most clinicians treat these patients with AEDs for a two-three year seizure-free period, just like as they would treat any other type of epilepsy. [13] Long-term follow-up studies of patients with SCG suggest that seizures associated with SCG should be treated with AEDs lesion. This economic burden is avoidable to a significant extent with well-designed public health measures and public health education as has been done in Reunion Island.
[21]
The principal aim of COI is to measure the economic burden of illness to the society. The COI can provide information to support the political process as well as the management functions at different levels of the healthcare organization.
[22] However, its usefulness as a policy decision-making tool has been questioned since its inception. [21] [22] [23] [24] Other forms of economic evaluation (e.g., cost-effectiveness, cost-benefit analysis) would be much more useful for those taking decisions and ranking priorities. [21, 25] However, COI evaluation of totally preventable diseases, like this one with considerable economic burden to the nation provides useful information for policymakers for effective preventive measures that 
Murthy et al.: Seizures associated with SCG -cost of illness
will be cost-saving and cost-effective. When considering the results of this economic evaluation the limitations of the study must be recognized. The costs involved reflect the protocol followed in this study and this treatment strategy has a sound scientific basis as discussed above. As regards cysticidal drug and steroid therapy, this is not a randomized control study. While evaluating indirect costs only man-days loss and wage loss were considered.
